Epidemiological studies have revealed that butyrate and 17β-estradiol (E2) may decrease the incidence of colorectal cancer (CRC). In peripheral tissue, E2 can be produced locally by 17β-hydroxysteroid dehydrogenase 1 (HSD17B1) estrone (E1) reduction. Using quantitative real-time polymerase chain reaction and western blotting analysis, we found that sodium butyrate significantly upregulates HSD17B1 long and short transcripts and protein levels in HT29 and SW707 CRC cells. Chromatin immunoprecipitation analysis showed that upregulation of these transcript levels correlated with an increase in binding of Polymerase II to proximal and distal promoters of HSD17B1. Moreover, we observed that upregulation of HSD17B1 protein levels was associated with increased conversion of E1 to E2 in HT29 and SW707 CRC cells. Since sodium butyrate increases the conversion of E1 to E2, our findings may support the validity of butyrate in the prophylaxis of CRC incidence.
Get full access to this article
View all access options for this article.
References
1.
ArcherS.Y., JohnsonJ., KimH.J., MaQ., MouH., DaesetyV., MengS., HodinR.A.2005. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol, 289:G696–G703.
2.
BassonM.D., TurowskiG.A., RashidZ., HongF., MadriJ.A.1996. Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. Dig Dis Sci, 41:1989–1993.
3.
Blank-PoratD., Gruss-FischerT., TarasenkoN., MalikZ., NudelmanA., RephaeliA.2007. The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties. Cancer Lett, 256:39–48.
4.
BrennerH., HoffmeisterM., ArndtV., HaugU.2007. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer, 96:828–831.
5.
CastiglioneF., TaddeiA., Degl'InnocentiD.R., BuccolieroA.M., BechiP., GarbiniF., ChiaraF.G., MonciniD., CavallinaG., MarascioL., FreschiG., GianL.T.2008. Expression of estrogen receptor beta in colon cancer progression. Diagn Mol Pathol, 17:231–236.
6.
ChenY.X., FangJ.Y., ZhuH.Y., LuR., ChengZ.H., QiuD.K.2004. Histone acetylation regulates p21WAF1 expression in human colon cancer cell lines. World J Gastroenterol, 10:2643–2646.
7.
ChomczynskiP., SacchiN.1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162:156–159.
8.
DahmC.C., KeoghR.H., SpencerE.A., GreenwoodD.C., KeyT.J., FentimanI.S., ShipleyM.J., BrunnerE.J., CadeJ.E., BurleyV.J., MishraG., StephenA.M., KuhD., WhiteI.R., LubenR., LentjesM.A., KhawK.T., Rodwell BinghamS.A.2010. Dietary fiber and colorectal cancer risk: a nested case-control study using food diaries. J Natl Cancer Inst, 102:614–626.
9.
FerlayJ., AutierP., BoniolM., HeanueM., ColombetM., BoyleP.2007. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol, 18:581–592.
10.
FiorelliG., PicarielloL., MartinetiV., TognariniI., TonelliF., BrandiM.L.2002. Estrogen metabolism in human colorectal cancer cells. J Steroid Biochem Mol Biol, 81:281–289.
11.
GametL., DaviaudD., Denis-PouxvielC., RemesyC., MuratJ.C.1992. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29. Int J Cancer, 52:286–289.
12.
GiovannucciE., StampferM.J., ColditzG.A., RimmE.B., TrichopoulosD., RosnerB.A., SpeizerF.E., WillettW.C.1993. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst, 85:875–884.
13.
GozziniA., RovidaE., Dello SbarbaP., GalimbertiS., SantiniV.2003. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. Cancer Res, 63:8955–8961.
14.
GumJ.R., KamW.K., ByrdJ.C., HicksJ.W., SleisengerM.H., KimY.S.1987. Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. J Biol Chem, 262:1092–1097.
15.
HamerH.M., JonkersD.M., BastA., VanhoutvinS.A., FischerM.A., KoddeA., TroostF.J., VenemaK., BrummerR.J.2009. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr, 28:88–93.
16.
HartmanJ., EdvardssonK., LindbergK., ZhaoC., WilliamsC., StromA., GustafssonJ.A.2009. Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res, 69:6100–6106.
17.
HayesJ.D., PulfordD.J.1995. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30:445–600.
18.
HeerdtB.G., HoustonM.A., AugenlichtL.H.1994. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res, 54:3288–3293.
19.
HermannS., RohrmannS., LinseisenJ.2009. Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg. Cancer Causes Control, 20:1397–1408.
20.
IacominoG., TecceM.F., GrimaldiC., TostoM., RussoG.L.2001. Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate. Biochem Biophys Res Commun, 285:1280–1289.
21.
JordanN.J., KoliosG., AbbotS.E., SinaiM.A., ThompsonD.A., PetrakiK., WestwickJ.1999. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J Clin Invest, 104:1061–1069.
22.
KimM.S., LeeJ., SidranskyD.2010. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev, 29:181–206.
23.
KimY.I.2005. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr, 135:2703–2709.
24.
KimY.S., TsaoD., SiddiquiB., WhiteheadJ.S., ArnsteinP., BennettJ., HicksJ.1980. Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer, 45:1185–1192.
25.
KondoY.2009. Epigenetic cross-talk between DNA methylation and histone modifications in human cancers. Yonsei Med J, 50:455–463.
26.
LeibovitzA., StinsonJ.C., McCombsW.B.3rd, McCoyC.E., MazurK.C., MabryN.D.1976. Classification of human colorectal adenocarcinoma cell lines. Cancer Res, 36:4562–4569.
27.
LouisM., RosatoR.R., BraultL., OsbildS., BattagliaE., YangX.H., GrantS., BagrelD.2004. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Int J Oncol, 25:1701–1711.
28.
LuczakM.W., JagodzinskiP.P.2006. The role of DNA methylation in cancer development. Folia Histochem Cytobiol, 44:143–154.
29.
LuczakM.W., JagodzinskiP.P.2008. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells. Cancer Lett, 272:53–60.
30.
LukacikP., KavanaghK.L., OppermannU.2006. Structure and function of human 17beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol, 248:61–71.
31.
Luu-TheV., LabrieC., SimardJ., LachanceY., ZhaoH.F., CouetJ., LeblancG., LabrieF.1990. Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase genes. Mol Endocrinol, 4:268–275.
32.
Luu-TheV., LabrieF.2010. The intracrine sex steroid biosynthesis pathways. Prog Brain Res, 181:177–192.
33.
Luu TheV., LabrieC., ZhaoH.F., CouetJ., LachanceY., SimardJ., LeblancG., CoteJ., BerubeD., GagneR.et al.1989. Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-termini in human placenta. Mol Endocrinol, 3:1301–1309.
34.
MariadasonJ.M.2008. HDACs and HDAC inhibitors in colon cancer. Epigenetics, 3:28–37.
35.
MartinetiV., PicarielloL., TognariniI., Carbonell SalaS., GozziniA., AzzariC., MaviliaC., TaniniA., FalchettiA., FiorelliG., TonelliF., BrandiM.L.2005. ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer, 12:455–469.
36.
MatanoskiG., TaoX.G., AlmonL., AdadeA.A., Davies-ColeJ.O.2006. Demographics and tumor characteristics of colorectal cancers in the United States, 1998–2001. Cancer, 107:1112–1120.
37.
MiettinenM.M., MustonenM.V., PoutanenM.H., IsomaaV.V., VihkoR.K.1996. Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression. Biochem J, 314,Pt 3:839–845.
38.
MindnichR., MollerG., AdamskiJ.2004. The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol, 218:7–20.
39.
NewmarkH.L., LuptonJ.R., YoungC.W.1994. Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. Cancer Lett, 78:1–5.
40.
OrchelA., DzierzewiczZ., ParfiniewiczB., WeglarzL., WilczokT.2005. Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent. Dig Dis Sci, 50:490–498.
41.
PajakB., OrzechowskiA., GajkowskaB.2007. Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv Med Sci, 52:83–88.
42.
ParkJ.K., ChoC.H., RamachandranS., ShinS.J., KwonS.H., KwonS.Y., ChaS.D. 2006. Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3-kinase inhibition in the human cervical cancer cell-line. Cancer Res Treat, 38:112–117.
43.
PellizzaroC., CoradiniD., DaidoneM.G.2002. Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. Carcinogenesis, 23:735–740.
44.
PoutanenM., IsomaaV., PeltoketoH., VihkoR.1995. Role of 17 beta-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis. J Steroid Biochem Mol Biol, 55:525–532.
45.
PoutanenM., MoncharmontB., VihkoR.1992. 17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Res, 52:290–294.
46.
QiuY., LangmanM.J., EggoM.C.2004. Targets of 17beta-oestradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy?J Endocrinol, 181:327–337.
47.
RadonicA., ThulkeS., MackayI.M., LandtO., SiegertW., NitscheA.2004. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun, 313:856–862.
48.
RennertG., RennertH.S., PinchevM., LavieO., GruberS.B.2009. Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol, 27:4542–4547.
49.
RiesL.A., WingoP.A., MillerD.S., HoweH.L., WeirH.K., RosenbergH.M., VernonS.W., CroninK., EdwardsB.K.2000. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer, 88:2398–2424.
50.
RossouwJ.E., AndersonG.L., PrenticeR.L., LaCroixA.Z., KooperbergC., StefanickM.L., JacksonR.D., BeresfordS.A., HowardB.V., JohnsonK.C., KotchenJ.M., OckeneJ.2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 288:321–333.
51.
SasanoH., SuzukiT., TakeyamaJ., UtsunomiyaH., ItoK., ArigaN., MoriyaT.2000. 17-beta-hydroxysteroid dehydrogenase in human breast and endometrial carcinoma. A new development in intracrinology. Oncology, 59,Suppl 1:5–12.
52.
ScharlauD., BorowickiA., HabermannN., HofmannT., KlenowS., MieneC., MunjalU., SteinK., GleiM.2009. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res, 682:39–53.
53.
SharpL., LittleJ., BrocktonN.T., CottonS.C., MassonL.F., HaitesN.E., CassidyJ.2008. Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case-control study in a population with relatively low folate intake. Br J Nutr, 99:379–389.
54.
SimpsonE.R.2003. Sources of estrogen and their importance. J Steroid Biochem Mol Biol, 86:225–230.
55.
SonnemannJ., HartwigM., PlathA., Saravana KumarK., MullerC., BeckJ.F.2006. Histone deacetylase inhibitors require caspase activity to induce apoptosis in lung and prostate carcinoma cells. Cancer Lett, 232:148–160.
TarasenkoN., NudelmanA., TarasenkoI., Entin-MeerM., Hass-KoganD., InbalA., RephaeliA.2008. Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex)Clin Exp Metastasis, 25:703–716.
58.
TeraoY., NishidaJ., HoriuchiS., RongF., UeokaY., MatsudaT., KatoH., FurugenY., YoshidaK., KatoK., WakeN.2001. Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells. Int J Cancer, 94:257–267.
59.
TheodoratouE., FarringtonS.M., TenesaA., McNeillG., CetnarskyjR., BarnetsonR.A., PorteousM.E., DunlopM.G., CampbellH.2008. Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 17:171–182.
60.
TornS., NokelainenP., KurkelaR., PulkkaA., MenjivarM., GhoshS., Coca-PradosM., PeltoketoH., IsomaaV., VihkoP.2003. Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem Biophys Res Commun, 305:37–45.
61.
van DuijnhovenF.J., Bueno-De-MesquitaH.B., FerrariP., JenabM., BoshuizenH.C., RosM.M., CasagrandeC., TjonnelandA., OlsenA., OvervadK., Thorlacius-UssingO., Clavel-ChapelonF., Boutron-RuaultM.C., MoroisS., KaaksR., LinseisenJ., BoeingH., NothlingsU., TrichopoulouA., TrichopoulosD., MisirliG., PalliD., SieriS., PanicoS., TuminoR., VineisP., PeetersP.H., van GilsC.H., OckeM.C., LundE., EngesetD., SkeieG., SuarezL.R., GonzalezC.A., SanchezM.J., DorronsoroM., NavarroC., BarricarteA., BerglundG., ManjerJ., HallmansG., PalmqvistR., BinghamS.A., KhawK.T., KeyT.J., AllenN.E., BoffettaP., SlimaniN., RinaldiS., GalloV., NoratT., RiboliE.2009. Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr, 89:1441–1452.
62.
VanhoutvinS.A., TroostF.J., HamerH.M., LindseyP.J., KoekG.H., JonkersD.M., KoddeA., VenemaK., BrummerR.J.2009. Butyrate-induced transcriptional changes in human colonic mucosa. PLoS ONE, 4:e6759.
63.
VihkoP., IsomaaV., GhoshD.2001. Structure and function of 17beta-hydroxysteroid dehydrogenase type 1 and type 2. Mol Cell Endocrinol, 171:71–76.
64.
von KleistS., ChanyE., BurtinP., KingM., FoghJ.1975. Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J Natl Cancer Inst, 55:555–560.
65.
WangL., LuoH.S., XiaH.2009. Sodium butyrate induces human colon carcinoma HT-29 cell apoptosis through a mitochondrial pathway. J Int Med Res, 37:803–811.
66.
WangY.F., ChenN.S., ChungY.P., ChangL.H., ChiouY.H., ChenC.Y.2006. Sodium butyrate induces apoptosis and cell cycle arrest in primary effusion lymphoma cells independently of oxidative stress and p21(CIP1/WAF1) induction. Mol Cell Biochem, 285:51–59.
67.
WeigeC.C., AllredK.F., AllredC.D.2009. Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res, 69:9118–9124.
68.
WilsonA.J., ChuehA.C., TogelL., CornerG.A., AhmedN., GoelS., ByunD.S., NasserS., HoustonM.A., JhawerM., SmarttH.J., MurrayL.B., NicholasC., HeerdtB.G., ArangoD., AugenlichtL.H., MariadasonJ.M.2010. Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Res, 70:609–620.
69.
XiL., ChenG., ZhouJ., XuG., WangS., WuP., ZhuT., ZhangA., YangW., XuQ., LuY., MaD.2006. Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway. Apoptosis, 11:789–798.
70.
YusaA., MiyazakiK., KimuraN., IzawaM., KannagiR.2010. Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells. Cancer Res, 70:4064–4073.
71.
ZhangY., ZhouL., BaoY.L., WuY., YuC.L., HuangY.X., SunY., ZhengL.H., LiY.X.2010. Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem Biol Interact, 185:174–181.
72.
ZhaoC., Dahlman-WrightK., GustafssonJ.A.2008. Estrogen receptor beta: an overview and update. Nucl Recept Signal, 6:e003.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
